Weaning is Winning? (WeWin Study)
Launched by THE HOSPITAL FOR SICK CHILDREN · Jul 24, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
The WeWin Study is a clinical trial focused on understanding how pediatric patients with intestinal failure can successfully stop using parenteral nutrition (PN), which is a way to get nutrients through an IV when the intestines aren’t working properly. The study aims to gather information from children under 18 years old who have been off PN for at least a year. This research is important because it can help improve the quality of life for young patients who rely on this type of nutrition.
If your child is eligible, they will join a multicenter study, meaning it will take place at multiple hospitals. The main requirement for participation is that they must have been using parenteral nutrition for at least one year and have a history of intestinal failure. It’s also essential that they or their guardians give consent to join the study. Participants can expect to be part of a supportive environment that aims to gather important data on their health journey and improve care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parenteral Nutrition graduates for at least 1 year, with a history of intestinal failure.
- • Age \<18 years at time of inclusion.
- Exclusion criteria:
- • No consent provided.
About The Hospital For Sick Children
The Hospital for Sick Children (SickKids) is a leading pediatric health care and research institution located in Toronto, Canada. With a commitment to advancing child health through innovative research, education, and clinical care, SickKids is recognized globally for its expertise in pediatric medicine. The hospital actively sponsors clinical trials aimed at improving treatment outcomes and enhancing the quality of life for children with various health conditions. By fostering collaboration among multidisciplinary teams and leveraging state-of-the-art facilities, SickKids strives to translate research findings into tangible advancements in pediatric care, ensuring that children receive the best possible treatments based on the latest scientific evidence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported